Custom service

Peptide Drugs Blood-brain Barrier Permeability Test Platform

Assess bbb permeability of peptide candidates with in-vitro models

Turnaround: 4–8 weeksTypical scale: 10^2 – 10^9 members by formatChemistry options: transwell (MDCK/Boelden-style) transport assays; PAMPA-BBB screening; efflux-ratio analysis

Peptide Drugs Blood-brain Barrier Permeability Test Platform supports programmes that assess BBB permeability of peptide candidates with in-vitro models. In a typical engagement we plan the transwell (MDCK/Boelden-style) transport assays route first, confirm compatibility with PAMPA-BBB screening, and release BBB permeability report with rank comparison on a 4–8 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep transwell (MDCK/Boelden-style) transport assays as the primary option and hold PAMPA-BBB screening in reserve, so that scale-up never depends on an unproven step.

CNS-programme candidate triage

Cyclo(Ala-Val)-style shuttle evaluation

In-vivo brain-exposure studies

Targets with no assayable readout and no purified protein available

Screening programmes close with a data package: primary screen statistics, confirmation data for each hit, counterscreen results and resynthesized material. Library lots ship with composition QC — representation and identity checks by LC-MS or NGS as the format requires.

Service Highlights

  • Transwell (MDCK/Boelden-style) transport assays as the default route, with PAMPA-BBB screening held as a proven fallback
  • Efflux-ratio analysis worked into the design where the application requires it
  • Every reported hit is confirmed by independent resynthesis and re-testing before it reaches you
  • Analytical confirmation of every intermediate before the final release
  • Library integrity (composition, representation) is measured, not assumed, before screening begins
  • BBB permeability report with rank comparison delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Library design

    Diversity, degeneracy and deconvolution strategy for Peptide Drugs Blood-brain Barrier Permeability Test Platform are fixed in a design document.

  2. Library synthesis or construction

    The library is built with transwell (MDCK/Boelden-style) transport assays and its composition is QC'd before screening.

  3. Primary screening

    Screening runs with PAMPA-BBB screening, with controls and statistics defined in advance.

  4. Hit deconvolution

    Hits are identified and ranked; counterscreens remove non-specific and promiscuous binders.

  5. Hit confirmation

    Every hit is resynthesized and re-tested; only reproducible hits advance.

  6. Hit delivery

    Confirmed hits and BBB permeability report with rank comparison are delivered with the full screening data package.

Specifications & timeline

Turnaround
4–8 weeks
Typical scale
10^2 – 10^9 members by format
Chemistry options
transwell (MDCK/Boelden-style) transport assays; PAMPA-BBB screening; efflux-ratio analysis
Deliverable
BBB permeability report with rank comparison
QC package
Library composition QC, screening raw data, hit confirmation package
Shipping
Ambient (plates, beads) or dry ice (display libraries)

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.